Technologies & Clinical validation
ABCDx expertise relies in the discovery, clinical validation and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries.
Brain Injury
ABCDx has completed the acquisition of exclusive commercial rights to patent applications that seek to protect the use of individual biomarkers and panels of biomarkers to categorize, differentiate and indicate treatment and management for patients with brain injury in the following categories:
ABCDx SA believes that use of its biomarker panels and its expertise will have the capability of transforming care of many brain injury patients by indicating appropriate and timely life-saving or life-changing treatments which could greatly improve clinical outcomes for a significantly larger proportion of patients.
biomarker validation
by Pr. Sanchez at UniGE
in patients CSF
of ABCDx
specificity of the ABCDx panel
Clinical studies
